Discussing a Tolerogenic Dendritic Cell Platform, Presenting the Antigen FVIII

Time: 10:00 am
day: Day Two


  • Discover a novel and patented platform for generation of tolerogenic DCs
  • Learn how tolerogenic DCs loaded with FVIII can be used to treat haemophilia A patients who developed inhibitors
  • Hear how the tolerogenic DCs have a potential to induce both regulatory T and B cells